Therefore, SDF4 was selected as the final candidate for a diagnostic biomarker in this study, as a potential serum diagnostic tumor marker for GC and other cancers (breast cancer, colorectal cancer, pancreatic cancer, esophageal cancer and hepatic cancer). The gene discussed is SDF4; the disease is cancer.